Department of Urology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Department of Pancreatic Surgery, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Front Endocrinol (Lausanne). 2024 Apr 4;15:1368079. doi: 10.3389/fendo.2024.1368079. eCollection 2024.
Previous studies have established that diabetes mellitus (DM) markedly raises the risk of developing erectile dysfunction (ED). Despite extensive investigations, the risk factors associated with ED in diabetic men have yet to be unequivocally determined, owing to incongruent and inconclusive results reported in various studies.
The objective of this systematic review and meta-analysis was to assess the risk factors for ED in men with DM.
A comprehensive systematic review was conducted, encompassing studies published in the PubMed, Scopus and Embase databases up to August 24th, 2023. All studies examining the risk factors of ED in patients with DM were included in the analysis. To identify significant variations among the risk factors, odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were employed. The risk of bias was evaluated using the Newcastle-Ottawa Scale(NOS) for longitudinal studies and the Agency for Healthcare Research and Quality Scale(AHRQ) for cross-sectional studies.
A total of 58 studies, including a substantial participant pool of 66,925 individuals diagnosed with DM, both with or without ED, were included in the meta-analysis. Mean age (OR: 1.31, 95% CI=1.24-1.37), smoking status (OR: 1.32, 95% CI=1.18-1.47), HbA1C (OR: 1.44, 95% CI=1.28-1.62), duration of DM (OR: 1.39, 95% CI=1.29-1.50), diabetic neuropathy (OR: 3.47, 95% CI=2.16-5.56), diabetic retinopathy (OR: 3.01, 95% CI=2.02-4.48), diabetic foot (OR: 3.96, 95% CI=2.87-5.47), cardiovascular disease (OR: 1.92, 95% CI=1.71-2.16), hypertension (OR: 1.74, 95% CI=1.52-2.00), microvascular disease (OR: 2.14, 95% CI=1.61-2.85), vascular disease (OR: 2.75, 95% CI=2.35-3.21), nephropathy (OR: 2.67, 95% CI=2.06-3.46), depression (OR: 1.82, 95% CI=1.04-3.20), metabolic syndrome (OR: 2.22, 95% CI=1.98-2.49), and diuretic treatment (OR: 2.42, 95% CI=1.38-4.22) were associated with increased risk factors of ED in men with DM.
Our study indicates that in men with DM, several risk factors for ED have been identified, including mean age, HbA1C, duration of DM, diabetic neuropathy, diabetic retinopathy, diabetic foot, cardiovascular disease, hypertension, microvascular disease, vascular disease, nephropathy, depression, metabolic syndrome, and diuretic treatment. By clarifying the connection between these risk factors and ED, clinicians and scientific experts can intervene and address these risk factors, ultimately reducing the occurrence of ED and improving patient management.
先前的研究已经证实,糖尿病(DM)会显著增加勃起功能障碍(ED)的发病风险。尽管进行了广泛的调查,但由于各种研究报告的结果不一致且没有定论,糖尿病男性发生 ED 的相关风险因素仍未得到明确确定。
本系统评价和荟萃分析的目的是评估糖尿病男性发生 ED 的风险因素。
我们进行了全面的系统评价,纳入了截至 2023 年 8 月 24 日在 PubMed、Scopus 和 Embase 数据库中发表的研究。所有研究均检查了糖尿病患者 ED 的风险因素。为了确定风险因素之间的显著差异,使用比值比(OR)及其相应的 95%置信区间(CI)进行分析。使用纽卡斯尔-渥太华量表(NOS)评估纵向研究的偏倚风险,使用医疗保健研究与质量局(AHRQ)量表评估横断面研究的偏倚风险。
共有 58 项研究,包括 66925 名患有 DM 的个体(包括有或没有 ED 的个体)的大量参与者,纳入了荟萃分析。平均年龄(OR:1.31,95%CI=1.24-1.37)、吸烟状况(OR:1.32,95%CI=1.18-1.47)、糖化血红蛋白(HbA1C)(OR:1.44,95%CI=1.28-1.62)、DM 持续时间(OR:1.39,95%CI=1.29-1.50)、糖尿病神经病变(OR:3.47,95%CI=2.16-5.56)、糖尿病视网膜病变(OR:3.01,95%CI=2.02-4.48)、糖尿病足(OR:3.96,95%CI=2.87-5.47)、心血管疾病(OR:1.92,95%CI=1.71-2.16)、高血压(OR:1.74,95%CI=1.52-2.00)、微血管疾病(OR:2.14,95%CI=1.61-2.85)、血管疾病(OR:2.75,95%CI=2.35-3.21)、肾病(OR:2.67,95%CI=2.06-3.46)、抑郁症(OR:1.82,95%CI=1.04-3.20)、代谢综合征(OR:2.22,95%CI=1.98-2.49)和利尿剂治疗(OR:2.42,95%CI=1.38-4.22)与男性 DM 患者 ED 风险因素增加相关。
我们的研究表明,在患有 DM 的男性中,已经确定了 ED 的几个风险因素,包括平均年龄、HbA1C、DM 持续时间、糖尿病神经病变、糖尿病视网膜病变、糖尿病足、心血管疾病、高血压、微血管疾病、血管疾病、肾病、抑郁症、代谢综合征和利尿剂治疗。通过阐明这些风险因素与 ED 之间的联系,临床医生和科学专家可以进行干预并解决这些风险因素,最终降低 ED 的发生并改善患者管理。